Tomczyk, M.; Braczko, A.; Mierzejewska, P.; Podlacha, M.; Krol, O.; Jablonska, P.; Jedrzejewska, A.; Pierzynowska, K.; Wegrzyn, G.; Slominska, E.M.;
et al. Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease. Cells 2022, 11, 2662.
https://doi.org/10.3390/cells11172662
AMA Style
Tomczyk M, Braczko A, Mierzejewska P, Podlacha M, Krol O, Jablonska P, Jedrzejewska A, Pierzynowska K, Wegrzyn G, Slominska EM,
et al. Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease. Cells. 2022; 11(17):2662.
https://doi.org/10.3390/cells11172662
Chicago/Turabian Style
Tomczyk, Marta, Alicja Braczko, Paulina Mierzejewska, Magdalena Podlacha, Oliwia Krol, Patrycja Jablonska, Agata Jedrzejewska, Karolina Pierzynowska, Grzegorz Wegrzyn, Ewa M. Slominska,
and et al. 2022. "Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease" Cells 11, no. 17: 2662.
https://doi.org/10.3390/cells11172662
APA Style
Tomczyk, M., Braczko, A., Mierzejewska, P., Podlacha, M., Krol, O., Jablonska, P., Jedrzejewska, A., Pierzynowska, K., Wegrzyn, G., Slominska, E. M., & Smolenski, R. T.
(2022). Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease. Cells, 11(17), 2662.
https://doi.org/10.3390/cells11172662